文献
J-GLOBAL ID:202202256824419278
整理番号:22A0576331
癌患者に対する抗SARS-CoV-2ワクチンの第三用量:体液性反応は監視すべきか?位置記事【JST・京大機械翻訳】
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article
著者 (9件):
Barriere Jerome
(Medical Oncology Department, Polyclinique Saint-Jean, 92 Avenue Dr Donat, FR-06800, Cagnes-sur-Mer, France)
,
Carles Michel
(Infectious Diseases Department, Cote D’Azur University, CHU de Nice, Hopital Archet 1, FR-06000, Nice, France)
,
Audigier-Valette Clarisse
(Pulmonology and Oncology Department, Centre Hospitalier Toulon Sainte-Musse, 54 rue Henri-Sainte-Claire-Deville, FR-83056 Toulon, France)
,
Re Daniel
(Department of Hematology and Medical Oncology, Centre Hospitalier Antibes Juan-les-Pins, 107 Route de Nice, FR-06600 Antibes, France)
,
Adjtoutah Zoubir
(Medical Biology Laboratory, Cerballiance Cote D’Azur, 52 Avenue des Alpes FR-06800, Cagnes-sur-Mer, France)
,
Seitz-Polski Barbara
(Department of Immunology & UR2CA, Cote D’Azur University, CHU Nice, 151 Route Saint-Antoine de Ginestiere FR-06200 Nice, France)
,
Gounant Valerie
(Thoracic Oncology Department & INSERM Centre D’Investigation Clinique 1425, Universite de Paris, University Institute of Cancer AP-HP North, Bichat-Claude Bernard Hospital, Assistance Publique-Hopitaux de Paris (AP-HP.Nord), 46 Rue Henri Huchard, Paris, France)
,
Descamps Diane
(Department of Virology and INSERM UMR 1137, Bichat-Claude Bernard Hospital, Assistance Publique-Hopitaux de Paris (AP-HP.Nord), 46 Rue Henri Huchard, Paris, France)
,
Zalcman Gerard
(Thoracic Oncology Department & INSERM Centre D’Investigation Clinique 1425, Universite de Paris, University Institute of Cancer AP-HP North, Bichat-Claude Bernard Hospital, Assistance Publique-Hopitaux de Paris (AP-HP.Nord), 46 Rue Henri Huchard, Paris, France)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
162
ページ:
182-193
発行年:
2022年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
オランダ (NLD)
言語:
英語 (EN)